Health

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1402

Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- 3SBio Inc. ("3SBio")'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. ("Sunshine Guojian") and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of a monoclonal antibody targeting VSIG4, as a ...

2020-12-14 22:28 1820

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 8635

Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration

HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...

2020-12-14 20:20 3913

Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation

TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...

2020-12-14 20:00 1980

Sai Life Sciences releases its first Sustainability Report

- Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path HYDERABAD, India, Dec. 14, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Resear...

2020-12-14 18:42 2075

Hummingbird Bioscience Announces Collaboration with Tempus to Harness AI-driven Precision Medicine to Accelerate Clinical Development of HMBD-001 In HER3 Driven Cancers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to drive t...

2020-12-14 18:00 1622

Ortoma launches OTS 5 according to plan

STOCKHOLM, Dec. 14, 2020 /PRNewswire/ -- Ortoma, manufacturer of surgical assistive technology for planning and positioning of implants, launches the latest version of the company's surgical system Ortoma Treatment Solution (OTS), which is based on AI (Artificial Intelligence). Ongoing active mar...

2020-12-14 16:28 1243

Exploring Breast Cancer from a 3-Dimensional Perspective

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Every October, the streets (and Internet) are rife with various awareness campaigns and pink ribbon projects that boost information on breast cancer and available screening methods. Despite an abundance of information available through mass-distributed br...

2020-12-14 15:31 1399

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- On December 13, 2020, the "Love & Hope" Gala Concert, organized by Huaxia Cultural Hub, was held in the Singapore Conference Hall, presenting a wonderful musical performance for locals. China Life Insurance (Singapore) Pte. Ltd. ("China Life Singapore")pro...

2020-12-14 14:44 2796

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...

2020-12-14 14:29 1845

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Plat...

2020-12-14 13:00 1285

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted onDecember 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company's strategy, personnel plans, technology platforms, integration strategic plans...

2020-12-14 12:15 2385

Global HealthTech Market will grow to US$ 456.85 Mn by 2028 at 19% CAGR- says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * The global healthtech market was valued atUS$ 96.11 Bn in 2019. The adoption of single use technology has experienced a rise in the healthcare industry durin...

2020-12-14 11:00 2401

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya "N...

2020-12-14 10:28 4421

Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium

TAIPEI and SAN DIEGO, Dec. 13, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer , announced their Abstract on Cholangiocarcinoma treatment with Silmit...

2020-12-14 10:09 1489

Global Respiratory Clinics Market will grow at a CAGR of 20.7% over the forecast period - says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ --   Respiratory Clinics Market will grow at a CAGR of 20.7% * In the United States currently more than 25 million people are diagnosed with asthma, because of thes...

2020-12-14 10:00 2257

High prevalence of hospital malnutrition associated with poor clinical outcomes

BAD HOMBURG, Germany, Dec. 14, 2020 /PRNewswire/ -- Hospital malnutrition is documented in many observational studies fromthe United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in...

2020-12-14 10:00 1922

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed') is a global innovative biopharmaceutical company. HopeMed recently announced that the current Chairman of the Scientific Advisory Board, DrHenri Nico Doods, will serve as the company's President, as well as Head of Research & ...

2020-12-14 09:00 5245

The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention

GENEVA and CASTRES , France, Dec. 14, 2020 /PRNewswire/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked...

2020-12-14 09:00 1853
1 ... 655656657658659660661 ... 847